New study shows cholesterol combination significantly reduced cardiovascular risks
Adding a drug called ezetimibe to statin therapy significantly reduced the risk of heart attack and stroke in high-risk patients with established heart disease, according to a long-awaited, large, randomized and controlled trial presented at the American Heart Association’s Scientific Sessions 2014.
- Read more about the study
- Find out what this may mean for your healthcare provider
Late-Breaking Clinical Trials from Scientific Sessions 2014: Anti-Lipid Therapy and Prevention of CAD
The newest heart disease and stroke prevention guidelines for doctors urge them to help you avoid heart disease and stroke by prescribing drugs called statins for some of you, treating obesity as a disease, and giving you other resources to stay healthy.
So what does that mean for you? Should you change your medications? Should you see a doctor for obesity treatment? How do you know if you’re healthy? These are among the questions you’ll find answers to here in the Guideline Resource Center.
The new guidelines focus on the very important areas of:
- Risk assessment
The cardiovascular prevention guidelines were released in November 2013 by the American Heart Association and the American College of Cardiology. These guidelines are basically recommendations for healthcare providers across the nation, created through years of scientific research.
- Highlights of the four new prevention guidelines
- We answer common questions about the new guidelines
- Letter to America: Why guidelines matter
- Doctors’ advice on the guidelines
- What the guidelines mean to you infographic
- About 12.8 million more adults eligible for discussions with their physicians to determine if statins are appropriate treatment
- Stroke prevention guidelines and preeclampsia
- Prevent another stroke by keeping blood pressure and lifestyle in check
- Guidelines for heart valve disease
- Guidelines for atrial fibrillation
- Guidelines aim to improve fetal care
- Guidelines for ischemic heart disease and women
|Understanding the Guidelines: A Conversation With AHA CEO Nancy Brown, President Mariell Jessup, M.D., and former President Sid Smith, M.D.||Former AHA President Gordon Tomaselli, M.D., who served on the volunteer task force overseeing development of the guidelines, answers basic guidelines questions.|